Financial Performance - The company reported a total revenue of 500 million RMB for the first half of 2023, representing a 20% increase compared to the same period last year[1]. - The company reported a total revenue of CNY 157.79 million for the first half of 2023, a decrease of 53.28% compared to the same period last year[21]. - The net profit attributable to shareholders was CNY -70.11 million, representing a decline of 537.35% year-over-year[21]. - The diluted earnings per share for the first half of 2023 was CNY -0.49, down 536.60% from CNY 0.11 in the previous year[21]. - The company’s gross margin dropped approximately 13.79 percentage points year-on-year, attributed to weak market demand and intense competition in the integrated circuit industry[22]. - The company reported a net cash flow from operating activities of CNY -183.62 million, reflecting ongoing financial challenges[21]. - The company’s weighted average return on equity was -6.58%, a decrease of 8.19 percentage points from the previous year[21]. - The company reported a total of 17 shares converted from the convertible bonds during the reporting period, with a cumulative conversion amount of CNY 1,000[167]. Research and Development - Research and development expenses increased by 18%, totaling 80 million RMB, to support innovation and new technology development[1]. - The company’s R&D expenditure accounted for 56.75% of its operating revenue, an increase of 29.29 percentage points compared to the previous year[21]. - The total R&D investment for the first half of 2023 was approximately ¥89.54 million, a decrease of 3.44% compared to ¥92.73 million in the same period last year[49]. - The number of R&D personnel increased to 356, a 39% rise compared to 256 in the same period last year, with R&D personnel accounting for 70.08% of the total workforce[55]. - The company has applied for 74 invention patents and received approval for 16 during the first half of 2023, demonstrating a commitment to innovation[64]. Product Development and Market Expansion - New product launches include the latest generation of semiconductor chips, which are expected to enhance performance by 30% over previous models[1]. - The company is expanding its market presence in Southeast Asia, targeting a 10% market share by the end of 2024[1]. - The company launched several new products in the industrial and automotive markets, enhancing its industry position[32]. - The company is progressing with the development of BMS products for electric vehicles and energy storage, with mass production expected to commence within the year[32]. - The company is focusing on expanding its market presence through innovative product offerings and strategic partnerships in the health technology sector[40]. Financial Challenges and Risks - The management highlighted potential risks including supply chain disruptions and increased competition in the semiconductor industry[1]. - The company faces risks related to market competition, particularly in high-precision ADC technology, which significantly impacts its revenue[68]. - The company’s gross profit margin is at risk due to potential fluctuations in raw material and packaging processing prices, which constitute 93.71% of its main business costs[74]. Corporate Governance and Shareholder Commitments - The board of directors confirmed that there are no significant governance issues affecting the company's operations[1]. - The company has committed to maintaining transparency and accountability in its operations and investor relations[120]. - The company has committed to repurchase all newly issued shares if it fails to meet the listing conditions, with a five-day response time after confirmation from regulatory authorities[122]. - The company will ensure that any share reduction after the lock-up period will not be below the adjusted issue price[115]. Cash Flow and Financial Management - Operating cash flow increased compared to the same period last year, primarily due to improved inventory management, resulting in reduced cash payments for goods and services[22]. - The company’s cash flow from operating activities showed a net outflow of -40,667,497.23 RMB in H1 2023, slightly worsening from -40,174,836.02 RMB in H1 2022[190]. - The company plans to issue convertible bonds to raise up to CNY 410 million to expand its business scale and enhance competitiveness[86]. - The company has temporarily invested RMB 1.0 billion of idle funds in cash management products, ensuring safety and liquidity[138]. Strategic Partnerships and Collaborations - The company has established partnerships with three major tech firms to enhance its product offerings and market reach[1]. - The company has established strategic partnerships with major clients, enhancing its competitive edge in high-end consumer markets such as smartphones and laptops[65]. Market Outlook - The global semiconductor market is expected to decline by 10.3% in 2023, with a total market size of USD 515 billion, influenced by inflation and weak end-market demand[30]. - The company aims to enhance its competitiveness and profitability by improving management levels, increasing R&D investment, and actively expanding the market[118].

| | | 芯海科技（深圳）股份有限公司 关于参加2023年半年度半导体行业专场 集体业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： http://roadshow.sseinfo.com/） 会议召开方式：上证路演中心视频录播结合网络文字互动 投资者可于 2023 年 09 月 01 日(星期五) 16:00 前通过邮件、电话、传真 等形式将需要了解和关注的问题提前提供给公司。公司将在文字互动环节对投资 者普遍关注的问题进行回答。 芯海科技（深圳）股份有限公司（以下简称"公司"）将于2023年08月31日 发布公司2023年半年度报告，为便于广大投资者更全面深入地了解公司2023年半 年度经营成果、财务状况、发展理念，公司将参与由上海证券交易所主办的2023 年半年度半导体行业专场集体业绩说明会，此次活动将采用视频录播结合网络文 字互动的方式举行，投资者可登录上海证券交易所上证路演中心（网址： http://roadshow.sseinfo.com/）参与线上互动交流。 一、说明会类型 ...

| | | 芯海科技（深圳）股份有限公司 关于召开2022年度暨2023年第一季度 业绩说明会的公告 芯海科技（深圳）股份有限公司（以下简称"公司"）已于2023年3月31日和 2023年4月29日分别发布公司2022年度报告及2023年第一季度报告，为便于广大 投资者更全面深入地了解公司2022年度及2023年第一季度经营成果、财务状况等 情况，公司计划于2023年05月15日（星期一）下午14:00-15:30举行2022年度暨2023 年第一季度业绩说明会，此次活动将采用视频录播和网络文字互动的方式举行， 投资者可登录上海证券交易所上证路演中心（网址：http://roadshow.sseinfo.com/） 参与线上互动交流。 会议召开时间：2023 年 05 月 15 日（星期一）下午 14:00-15:30 会议召开地点：上海证券交易所上证路演中心（网址： 一、说明会类型 二、说明召开的时间、地点 本次投资者说明会以视频录播结合网络文字互动形式召开，公司将针对 2022年度及2023年第一季度经营成果、财务状况等情况与投资者进行互动交流 和沟通，在信息披露允许的范围内就投资者普遍关注的问题进行回答 ...

Financial Performance - In Q1 2023, the company's revenue was CNY 61,659,280.95, a decrease of 58.60% compared to the same period last year[5]. - The net profit attributable to shareholders was a loss of CNY 48,954,819.46, representing a decline of 4,944.49% year-on-year[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was a loss of CNY 57,813,231.67, down 11,947.80% year-on-year[5]. - The basic and diluted earnings per share were both CNY -0.34, a significant decrease compared to the previous year[6]. - Total operating revenue for Q1 2023 was CNY 61,659,280.95, a decrease of 58.7% compared to CNY 148,930,282.07 in Q1 2022[19]. - Net loss for Q1 2023 was CNY 48,929,970.33, compared to a net profit of CNY 909,392.69 in Q1 2022[20]. - Basic and diluted earnings per share for Q1 2023 were both CNY -0.34, compared to CNY 0.01 in Q1 2022[21]. Research and Development - R&D expenses totaled CNY 50,899,379.15, accounting for 82.55% of revenue, an increase of 52.42 percentage points year-on-year[6]. - Research and development expenses increased to CNY 50,899,379.15 in Q1 2023, up from CNY 44,874,856.68 in Q1 2022, reflecting a growth of 13.5%[20]. Assets and Liabilities - The company's total assets at the end of the reporting period were CNY 1,648,443,432.63, a decrease of 3.07% from the end of the previous year[6]. - Total assets as of Q1 2023 were CNY 1,648,443,432.63, a decrease from CNY 1,700,729,056.95 in the previous year[18]. - Total liabilities for Q1 2023 were CNY 582,983,313.75, down from CNY 603,655,609.42 in Q1 2022[18]. - The total liabilities stood at 578,405,206.19 RMB, with current liabilities totaling 238,734,303.44 RMB[29]. - Total liabilities amounted to $603.66 million, a slight decrease from $606.06 million in the previous period, reflecting a change of approximately 0.07%[30]. Cash Flow - The company reported a net cash flow from operating activities of CNY -47,338,653.33, indicating a negative cash flow situation[5]. - The company's cash flow from operating activities showed a significant decline, impacting overall liquidity[22]. - In Q1 2023, the net cash flow from operating activities was -47,338,653.33 RMB, compared to -39,623,311.31 RMB in Q1 2022, indicating a decline of approximately 19.4% year-over-year[24]. - Total cash inflow from investment activities was 94,226,530.78 RMB, while cash outflow was 15,918,115.31 RMB, resulting in a net cash flow from investment activities of 78,308,415.47 RMB, a significant recovery from -25,140,797.52 RMB in the previous year[25]. - The company reported a net increase in cash and cash equivalents of 26,037,120.88 RMB in Q1 2023, contrasting with a decrease of -66,306,710.01 RMB in Q1 2022[25]. Market Conditions - The overall market demand for the semiconductor industry remained weak, continuing the trend from the second half of 2022[6]. - The company plans to focus on market expansion and new product development to improve future performance[22]. Strategic Focus - The company is focusing on expanding its market presence and developing new technologies, although specific figures were not disclosed in the report[14]. - The company is actively managing its cash flow, as evidenced by the strategic adjustments in its operating and investment activities[25]. - The company is focusing on expanding its investment activities, as indicated by the significant cash inflow from investment activities in Q1 2023[25]. Accounting and Reporting - The company has adjusted its accounting policies in accordance with the new accounting standards effective from January 1, 2023, impacting the financial statements[26]. - There are no indications of any financing or margin trading activities by the major shareholders[13]. - The company has not reported any significant mergers or acquisitions during the quarter[14].

Share Repurchase and Dividends - The company repurchased 1,071,844 shares with a total amount of RMB 60,018,526.11 (excluding taxes and transaction fees) from May to July 2022[5] - The cash dividend ratio for 2022 was 2147.06% of the net profit attributable to ordinary shareholders in the consolidated financial statements[5] - The company decided not to distribute cash dividends, issue bonus shares, or convert capital reserves into share capital for 2022, with undistributed profits carried forward to future years[5] Company Information - Chipsea Technologies (Shenzhen) Corp., Ltd. is listed on the Shanghai Stock Exchange's STAR Market with the stock code 688595[21] - The company's registered and office address is located at 1st Building, 301, Shenzhen Bay Innovation Technology Center, Keji Avenue, Nanshan District, Shenzhen, with a postal code of 518000[17][18] - The company's legal representative is Lu Guojian[17] - The company's website is www.chipsea.com and the email contact is info@chipsea.com[18] - The company's annual report is disclosed on media platforms including "China Securities Journal," "Shanghai Securities News," "Securities Times," and "Securities Daily," and is also available on the Shanghai Stock Exchange website[20] - The company's annual report is prepared at the Board of Directors Office[20] Financial Performance - Revenue in 2022 was RMB 6,176.72 million, a decrease of 6.28% year-over-year[24] - Net profit attributable to shareholders was RMB 2.80 million, a significant decline of 97.08% compared to the previous year[24] - Net profit attributable to shareholders after deducting non-recurring gains and losses was RMB -40.14 million, a decrease of 138.89% year-over-year[24] - Operating cash flow was RMB -85.55 million, a decrease of 169.99% compared to 2021[24] - Total assets increased by 52.10% to RMB 1,700.73 million at the end of 2022[24] - Revenue for 2022 was RMB 617.67 million, a decrease of 6.28% year-over-year, primarily due to weak demand in 8-bit MCU and consumer electronics sectors[101] - Operating costs increased by 19.18% to RMB 375.61 million, driven by changes in product sales structure[101] - Gross margin decreased by 13 percentage points to 39.19% due to weak demand, increased market competition, and higher procurement costs[103] - Net cash flow from operating activities was negative RMB 85.55 million, a significant decline of 169.99% year-over-year, due to slower customer payments and increased inventory purchases[101] - Revenue from the health measurement segment decreased by 35.99% to RMB 146.60 million, with a corresponding 24.99% decrease in costs[104] - Revenue from the analog signal chain chip segment increased by 40.36% to RMB 171.01 million, driven by large-scale shipments of BMS chips to key customers[104] - MCU chip segment revenue decreased by 2.09% to RMB 288.99 million, with costs increasing by 37.22% due to a shift in product mix towards higher-cost 32-bit MCUs[104] - Domestic revenue accounted for RMB 597.78 million, a decrease of 4.47%, while international revenue decreased by 43.54% to RMB 15.02 million[105] - Production volume of health measurement products decreased by 50.10% to 12.22 million units, with sales volume dropping by 54.25%[106] - MCU chip sales volume reached 28,960.83 thousand units, a year-on-year decrease of 7.73%[107] - Overall production and sales rate of main products was 98.07%, with MCU chip production and sales rate at 107.40%, a year-on-year increase of 9.51%[107] - Total cost of raw materials for integrated circuits increased by 27.48% to 253,596,278.14 yuan[107] - Sales to the top five customers accounted for 39.84% of total annual sales, totaling 24,609.50 million yuan[108][110] - Procurement from the top five suppliers accounted for 76.11% of total annual procurement, totaling 40,677.14 million yuan[112][115] - Net cash flow from financing activities increased to 537,300,492.21 yuan, mainly due to the issuance of convertible bonds[119] - Disposal of Tongfu Microelectronics stock resulted in an investment income of 9.4 million yuan, and government subsidies contributed approximately 39 million yuan[120] - Cash and cash equivalents increased by 66.79% to 636,822,512.76 RMB, accounting for 37.44% of total assets, primarily due to funds raised from the issuance of convertible bonds[122] - Trading financial assets increased by 80.86% to 94,161,187.22 RMB, accounting for 5.54% of total assets, mainly due to increased financial management activities[122] - Accounts receivable increased by 88.43% to 255,474,574.94 RMB, accounting for 15.02% of total assets, driven by reduced customer repayments due to the economic downturn[122] - Inventory increased by 62.01% to 206,183,518.96 RMB, accounting for 12.12% of total assets, due to changes in product structure and increased stock of higher-cost items[122] - Other current assets increased by 58.43% to 52,036,228.86 RMB, accounting for 3.06% of total assets, mainly due to an increase in tax credits[122] - Other equity instrument investments increased by 55.56% to 28,000,000.00 RMB, accounting for 1.65% of total assets, due to increased equity investments[122] - Short-term borrowings amounted to 130,359,027.78 RMB, accounting for 7.66% of total assets, primarily due to new low-cost working capital loans[122] - Bonds payable amounted to 339,670,902.75 RMB, accounting for 19.97% of total assets, due to the issuance of convertible bonds[123] - Overseas assets totaled 31,482.57 RMB, accounting for 0.002% of total assets[125] - Investment in land for self-built office spaces amounted to 21,655,027 RMB, as part of the change in the implementation method of fundraising projects[130] - The company's total assets at the end of the period amounted to 122,919,713.22 yuan, with a decrease in fair value changes of -1,902,049.34 yuan during the period[133] - The company invested 114,000,000 yuan in bank wealth management products during the period, with an ending balance of 94,161,187.22 yuan[133] - The company's investment in the private equity fund "Hainan Huoyan Xihe Equity Investment Fund" amounted to 10,000,000 yuan, with a total investment of 123,390,121 yuan across 10 projects, accounting for 71.04% of the fund's total size[137] - The company's subsidiary, Hefei Xinhai Electronics Technology Co., Ltd., reported a net profit of 2,408.53 million yuan, with total assets of 29,827.21 million yuan and net assets of 25,109.92 million yuan[138] - The company's subsidiary, Xi'an Xinhai Microelectronics Technology Co., Ltd., reported a net loss of -1,952.92 million yuan, with total assets of 768.76 million yuan and net assets of -1,516.56 million yuan[138] - The company's subsidiary, Shenzhen Kangyou Health Technology Co., Ltd., reported a net profit of 59.06 million yuan, with total assets of 303.14 million yuan and net assets of 21.54 million yuan[138] - The company's subsidiary, Shenzhen Xinhai Chuangxin Technology Co., Ltd., reported a net loss of -145.93 million yuan, with total assets of 4,597.86 million yuan and net assets of -552.53 million yuan[138] - The company's subsidiary, Chengdu Xinhai Chuangxin Technology Co., Ltd., reported a net loss of -696.52 million yuan, with total assets of 5,665.66 million yuan and net assets of 4,261.21 million yuan[138] - The company's subsidiary, Shanghai Xinhai Technology Co., Ltd., reported a net loss of -2,104.37 million yuan, with total assets of 686.91 million yuan and net assets of -1,474.59 million yuan[138] R&D and Innovation - R&D investment accounted for 30.13% of revenue, an increase of 4.47 percentage points from 2021[25] - MCU chip sales in 2022 were RMB 2,889.96 million, a slight decrease of 2.09% year-over-year, with high-performance 32-bit MCUs accounting for 62% of MCU product sales[26] - Analog signal chain chip sales grew by 40.36% to RMB 1,710.05 million, with BMS shipments increasing by 808% year-over-year[26] - Health measurement AIOT chip sales declined by 35.99% to RMB 1,466.03 million, primarily due to weak consumer demand[27] - R&D investment in 2022 totaled 186.1307 million yuan, a year-on-year increase of 10.06%, accounting for 30.13% of revenue, up 4.47 percentage points[38] - The number of R&D technical personnel increased to 345, a year-on-year growth of 21.05%, accounting for 68.86% of total employees[38] - The proportion of R&D personnel with master's or doctoral degrees reached 62.03%, an increase of 9.4 percentage points[39] - In 2022, the company applied for 114 new invention patents and was granted 18, while applying for 37 new utility model patents and being granted 62[39] - Cumulative invention patent applications reached 600, with 175 granted, and utility model patent applications totaled 245, with 208 granted[39] - The company made significant breakthroughs in markets such as BMS, industrial measurement and control, smart meters, PCs, and automotive electronics[41] - The company's 32-bit MCU chip sales grew by 75.02% year-over-year, with sales accounting for over 60% of total MCU revenue[59] - The company's single-cell lithium battery management BMS chip achieved mass production, with shipments reaching tens of millions of units[57] - The company's high-reliability industrial-grade sensor conditioning chips began mass production, targeting industrial and automotive applications[58] - The company's PD series MCU products expanded into the energy storage and power tool markets, achieving mass production[59] - The company's health measurement AIoT solutions achieved a commercial-grade accuracy of 0.97, with over 1 million units shipped for blood oxygen measurement solutions[60] - The company's AIoT business, leveraging OpenHarmony, achieved over 10 million units shipped across 11 categories and 61 SKUs[61] - The company's automotive MCU business is progressing well, with multiple automotive-grade MCU chips entering testing and mass production phases, and ASIL-D compliant products expected in 2023[60] - The company's new generation of high-precision Sigma-Delta ADC and high-speed SAR ADC for automotive applications is under development, with products expected to launch in 2023[58] - High-precision ADC technology has achieved mass production, with significant cost advantages over international competitors like TI and ADI, helping downstream manufacturers quickly enhance product technical content[64] - The high-precision reference source technology has improved measurement accuracy through second-order temperature compensation and dynamic device matching, meeting market demands for high-precision measurement[64] - Human impedance measurement technology has reduced the cost of 4/8-electrode body fat scales and human composition analyzers by 1%, with impedance measurement accuracy reaching 1% and phase angle accuracy at ±0.5[64] - The multi-frequency algorithm for human body composition analysis has achieved a correlation coefficient of 0.97 with the DEXA gold standard, positioning it as a leader in the domestic market[65] - The high-reliability MCU technology has enhanced ESD performance to 8KV and EFT performance to 4KV, enabling widespread application in various fields and replacing foreign products[65] - The company's ADC technology has improved signal input range, reduced chip noise, and minimized power supply noise impact, making it suitable for various application scenarios[64] - The human impedance measurement chip supports multi-frequency and multi-electrode measurements, significantly improving accuracy and dynamic range for high-end applications like 8-electrode body composition analyzers[65] - The MCU technology has improved reliability through research on reset circuits, clock circuits, and storage circuits, achieving high performance in different application scenarios[65] - The company's ADC technology has forced a sharp decline in the prices of overseas products, promoting rapid development in related industries[64] - The human impedance measurement technology has expanded low-cost multi-parameter measurements, including heart rate, phase angle, weight, and balance, significantly enhancing the value of body fat scales[65] - High-precision ForceTouch technology for pressure touch control has been widely adopted by major smartphone manufacturers including vivo, Xiaomi, and Meizu, achieving mass production[66] - The company's Bluetooth application technology for smart health products has reduced development time for Bluetooth body fat scales to 7-15 days, accelerating industry adoption and upgrading[66] - The battery monitoring technology for lithium management features high precision and integration, addressing the market dominated by TI and overcoming trade restrictions[67] - The company's pressure sensor measurement technology achieves high-speed and low-power consumption, suitable for smart terminals like smartphones, TWS, and tablets[66] - The Bluetooth body fat scale software solutions have standardized functions such as communication handshake, data transmission, and online upgrades, improving product usability and stability[66] - The adaptive gain adjustment and high-precision fast-response incremental Σ-Δ ADC technology for battery monitoring is under patent application, targeting low power consumption and high accuracy[67] - The company's pressure sensor signal measurement architecture resolves the challenge of measuring weak signals with high speed and low power consumption, validated in real-world applications[66] - The Bluetooth technology has facilitated the transition of traditional weighing scales to smart body fat scales, driving industry-wide upgrades[66] - The company's battery monitoring chip integrates multiple high-performance modules, offering a competitive alternative to TI's monopoly in the high-performance battery monitoring market[67] - The pressure sensor technology based on the Wheatstone bridge structure achieves high-speed, low-power measurement, making it suitable for human-computer interaction in smart devices[66] - The company's R&D investment in 2022 increased by 10.06% year-on-year, reaching RMB 186.13 million, with R&D expenses accounting for 30.13% of total revenue, an increase of 4.47 percentage points compared to the previous year[75] - In 2022, the company applied for 114 new invention patents, 37 utility model patents, and 18 software copyrights, with a cumulative total of 600 invention patents, 245 utility model patents, and 191 software copyrights applied for[72][73] - The company's R&D personnel increased by 21.05% to 345 people by the end of 2022, with a 39.74% increase in total R&D personnel compensation[76] - The company's embedded controller for laptops achieved a maximum frequency of 60MHz, with DMIPS/MHz of 1.05 and Cormark/MHz of 2.24, surpassing competitors in low-power design[68] - The company's automotive-grade MCU technology achieved ISO 26262 ASIL-D functional safety level and AEC-Q100 Grade0/1 reliability, breaking the monopoly of foreign companies in the automotive chip market[69] - The company's R&D investment in 2022 included a 75.77% increase in depreciation and amortization due to the purchase of new EDA tools, software, and IP assets[76] - The company's R&D auxiliary materials and testing fees increased by 9.59% year-on-year in 2022[76] - The company's embedded controller for laptops supports multiple low-power modes, with VBAT mode power consumption below 6uA, exceeding the level of foreign competitors[68] - The company's automotive-grade MCU technology meets the ISO 26262 design standard and AEC-Q100 Grade1 testing standard, with some even requiring Grade0 standards[69] - The company's embedded controller for laptops integrates AES, RSA, HASH, TRNG hardware encryption modules, supporting secure boot and secure online upgrades[68] - The company's R&D personnel increased to 345, up 21.05% YoY, with master's and doctoral degree holders accounting for 62.03% of the total R&D staff, an increase of 9.4 percentage points[82] - The company has invested a total of RMB 29.633 billion in R&D projects, with a cumulative investment of RMB 18.613 billion in the current period[79] - The company's high-precision ADC technology has reached domestic leading and internationally advanced levels, with a 24-bit Sigma-Delta ADC being the first of its kind in China[85] - The company has launched the first global resistive micro-pressure strain technology-based pressure touch SoC chip, which is used in mobile phones and TWS earphones[85] - The company has developed a 32-bit MCU with built-in USB PD3.0 fast charging protocol, which has been adopted by leading domestic customers[85] - The company has introduced notebook motherboard controller chips with higher integration and better security compared to overseas competitors, and these have been adopted by leading customers[85] - The company has developed multiple automotive-grade MCU chips, which are now being introduced to clients[85] - The company has accumulated 600 patent applications, with 175 patents granted (including 2 US patents), and has won the "China IC" award six times[86] - The company has been recognized as a national-level "Little Giant" enterprise and a "Guangdong Province IoT Chip Development and Application Engineering Technology Research Center"[86] - R&D team accounts for 68.86% of the company's total workforce, emphasizing delivery capability and technical advancement[87] Strategic Focus and Market Expansion - The company strengthened its layout in the automotive electronics market, releasing multiple automotive-grade chips and establishing strategic partnerships with industry-leading customers[40] - The company has implemented organizational reforms in 2022, including LTC (Leads To Cash) and ITR (Issue to Resolved) areas, and introduced CRM and

Group 1: Company Overview and Market Position - The company, Chipsea Technology (Shenzhen) Co., Ltd., focuses on MCU applications in various fields, including consumer electronics, industrial control, and communication [1] - In 2021, the high-performance 32-bit MCU market share increased from approximately 10% in 2020 to around 40% in 2021, with a projected 50% share in Q1 2022 [1] - The company has established industry benchmark clients and continues to expand its market presence [1] Group 2: Product Applications and Development - The company's computer-related products include EC chips for laptops, USB Type-C and PD protocol chips, and high-precision pressure touch chips [1] - BMS chips have started mass shipments since Q4 2021, contributing significant revenue growth, with a nearly 60% quarter-on-quarter increase in Q1 2022 [2] - The company plans to launch multi-cell BMS products for laptops, power tools, and robotic vacuums, leveraging high-precision ADC technology [2] Group 3: R&D Investment and Future Plans - R&D investment reached 44.87 million in Q1 2022, an increase of 14 million year-on-year, focusing on advancements in industrial, computer, and automotive electronics [2] - The company emphasizes continuous innovation in ADC technology, with plans to expand product offerings based on market demand [2] - The development of automotive MCU chips is progressing as planned, with applications in body control and power systems [2] Group 4: Impact of External Factors - The company reported no significant impact from the domestic pandemic on overall production and operations, maintaining normal business activities [3]

2022 年第三季度报告 证券代码：688595 证券简称：芯海科技 芯海科技（深圳）股份有限公司 2022 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务 信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 | 项目 | 本报告期 | 本报告期比 | 年初至报告期末 | 年初至报告期 | | --- | --- | --- | --- | --- | | | | 上年同期增 | | 末比上年同期 | | | | 减变动幅度 | | 增减变动幅度 | | | | (%) | | (%) | | 营业收入 | 147,984,851.15 | -21.34 | 485,735,8 ...

2022 年半年度报告 公司代码：688595 公司简称：芯海科技 芯海科技（深圳）股份有限公司 2022 年半年度报告 1 / 172 2022 年半年度报告 重要提示 一、 本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、准确性、 完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 重大风险提示 公司已在本报告中详细描述了公司在经营过程中可能面临的各种风险及应对措施，敬请查阅 本报告"第三节 管理层讨论与分析"。 三、 公司全体董事出席董事会会议。 四、 本半年度报告未经审计。 五、 公司负责人卢国建、主管会计工作负责人谭兰兰及会计机构负责人（会计主管人员）谭兰兰 声明：保证半年度报告中财务报告的真实、准确、完整。 六、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 无 七、 是否存在公司治理特殊安排等重要事项 □适用 √不适用 八、 前瞻性陈述的风险声明 □适用 √不适用 九、 是否存在被控股股东及其关联方非经营性占用资金情况 否 十、 是否存在违反规定决策程序对外提供担保的情况？ 否 十一、 是否存在半数以上董事无法保证公司所披露半年 ...

2022 年第一季度报告 证券代码：688595 证券简称：芯海科技 芯海科技（深圳）股份有限公司 2022 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准 确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责 任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报 告中财务报表信息的真实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 | 项目 | 本报告期 | 本报告期比上 | | | --- | --- | --- | --- | | | | 年同期增减变 | | | | | 动幅度(%) | | | 营业收入 | | 148,930,282.07 | 43.76 | | 归属于上市公司股东的净 | | 1,010,526.73 | 不适用 | | 利润 | | | | 1 / 15 2022 ...

[Report Overview](index=1&type=section&id=Report%20Overview) This section provides an overview of the unaudited Q3 2021 report, with management assuring its accuracy and completeness [Important Notes](index=1&type=section&id=Important%20Notes) The Q3 2021 report is unaudited, with the board and management guaranteeing its accuracy and completeness - The financial statements for this reporting period are unaudited[4](index=4&type=chunk) - The company's board of directors, supervisory board, and senior management guarantee the truthfulness, accuracy, and completeness of the quarterly report content[2](index=2&type=chunk)[3](index=3&type=chunk) [Key Financial Data](index=1&type=section&id=I.%20Key%20Financial%20Data) This section details Chipsea Technologies' key financial performance, including revenue, net profit, R&D, and balance sheet changes [Key Accounting Data and Financial Indicators](index=1&type=section&id=(I)%20Key%20Accounting%20Data%20and%20Financial%20Indicators) Chipsea Technologies' Q3 2021 and YTD financial indicators show strong revenue and net profit growth, increased R&D, but a decline in weighted average ROE [Financial Indicators Overview](index=1&type=section&id=Financial%20Indicators%20Overview) This section presents a summary of key financial performance metrics for Q3 2021 and year-to-date, including revenue, net profit, and R&D investment Key Accounting Data and Financial Indicators for Q3 2021 and Year-to-Date | 项目 | Current Period (Q3 2021) (Yuan) | YoY Change (%) | Year-to-Date (YTD 2021) (Yuan) | YoY Change (%) | | :--- | :--- | :--- | :--- | :--- | | Operating Revenue | 188,122,218.79 | 99.50 | 462,704,841.83 | 82.39 | | Net Profit Attributable to Shareholders | 35,575,402.68 | 129.21 | 82,924,298.72 | 36.63 | | Net Profit Attributable to Shareholders Excluding Non-Recurring Items | 47,516,888.91 | 287.08 | 94,249,556.67 | 80.07 | | Net Cash Flow from Operating Activities | N/A | N/A | 97,564,919.25 | 13,432.93 | | Basic Earnings Per Share (Yuan/share) | 0.36 | 71.43 | 0.83 | 2.47 | | Diluted Earnings Per Share (Yuan/share) | 0.36 | 71.43 | 0.83 | 2.47 | | Weighted Average Return on Net Assets (%) | 4.06 | Decrease by 0.73 percentage points | 9.32 | Decrease by 10.81 percentage points | | Total R&D Investment (Yuan) | 39,732,074.02 | 131.77 | 103,747,868.69 | 111.35 | | R&D Investment as % of Operating Revenue | 21.12 | Increase by 2.94 percentage points | 22.42 | Increase by 3.07 percentage points | Balance Sheet Indicators as of Q3 2021 and Year-End 2020 | 项目 | Current Period End (Sep 30, 2021) (Yuan) | Previous Year End (Dec 31, 2020) (Yuan) | Change (%) | | :--- | :--- | :--- | :--- | | Total Assets | 1,068,652,957.48 | 1,021,012,690.10 | 4.67 | | Owners' Equity Attributable to Shareholders | 938,135,261.81 | 858,227,532.41 | 9.31 | [Profitability Data Excluding Specific Factors](index=2&type=section&id=Profitability%20Data%20Excluding%20Specific%20Factors) This section details adjusted profitability metrics after excluding the impact of specific non-recurring items and share-based payments - Excluding the impact of **RMB 16.80 million** investment loss from Tongfu Microelectronics and **RMB 37.21 million** in share-based payments for January-September 2021, net profit attributable to shareholders was **RMB 136.935 million**, a **125.62% year-over-year increase**[7](index=7&type=chunk) - Excluding the impact of **RMB 13.5852 million** investment loss from Tongfu Microelectronics and **RMB 13.5944 million** in share-based payments for Q3 2021, Q3 net profit attributable to shareholders was **RMB 62.755 million**, a **304.32% year-over-year increase**[7](index=7&type=chunk) - Excluding the impact of **RMB 37.21 million** in share-based payments for January-September 2021, non-recurring net profit attributable to shareholders was **RMB 131.4596 million**, a **151.16% year-over-year increase**[7](index=7&type=chunk) - Excluding the impact of **RMB 13.5944 million** in share-based payments for Q3 2021, Q3 non-recurring net profit attributable to shareholders was **RMB 61.1113 million**, a **397.83% year-over-year increase**[7](index=7&type=chunk) Profitability Data Excluding Non-Operating Factors | 项目 | Jan-Sep 2021 (RMB Million) | Jan-Sep 2020 (RMB Million) | YoY Change (%) | Q3 2021 (RMB Million) | YoY Change (%) | | :--- | :--- | :--- | :--- | :--- | :--- | | Net Profit Attributable to Shareholders | 136.9350 | 60.6920 | 125.62 | 62.7550 | 304.32 | | Net Profit Attributable to Shareholders Excluding Non-Recurring Items | 131.4596 | 52.3401 | 151.16 | 61.1113 | 397.83 | [Non-Recurring Gains and Losses Items and Amounts](index=3&type=section&id=(II)%20Non-Recurring%20Gains%20and%20Losses%20Items%20and%20Amounts) During the reporting period, the company's total non-recurring gains and losses were negative, primarily influenced by losses from disposal of non-current assets, government grants, entrusted investment income, and fair value changes of financial assets Non-Recurring Gains and Losses Items for Q3 2021 and Year-to-Date | 项目 | Current Period Amount (Yuan) | Year-to-Date Amount (Yuan) | | :--- | :--- | :--- | | Disposal gains/losses on non-current assets | -3,194.92 | -3,194.92 | | Government grants recognized in current profit/loss | 1,577,153.05 | 4,633,429.34 | | Gains/losses from entrusted investments or asset management | 249,907.30 | 818,598.75 | | Gains/losses from changes in fair value of trading financial assets/liabilities and disposal of investment income | -13,585,206.96 | -16,800,640.56 | | Other non-operating income and expenses | -180,037.24 | -131,834.70 | | Other non-recurring gains/losses as defined | 167,511.52 | 0 | | Less: Income tax impact | 67.16 | 5,173.36 | | Minority interest impact (after tax) | 40.30 | 3,954.02 | | Total | -11,941,486.23 | -11,325,257.95 | [Changes and Reasons for Key Accounting Data and Financial Indicators](index=5&type=section&id=(III)%20Changes%20and%20Reasons%20for%20Key%20Accounting%20Data%20and%20Financial%20Indicators) During the reporting period, the company's revenue, net profit, and R&D investment all significantly increased, driven by strong industry conditions, robust market demand, comprehensive product line growth, and improved management efficiency. Operating cash flow also saw a substantial increase, reflecting healthy sales collections - Year-to-date revenue increased by **82.39%**, with a **99.50% increase** in the current period, primarily due to high industry prosperity and sustained strong demand in 2021, leading to rapid growth across all product lines including analog signal chain chips, MCU chips, and health measurement AIoT chips[11](index=11&type=chunk) - Net profit attributable to shareholders increased by **36.63%** year-to-date and **129.21%** in the current period; excluding share-based payments and Tongfu Microelectronics stock investment losses, year-to-date growth was **125.62%** and current period growth was **304.32%**, mainly due to revenue growth and improved management efficiency[11](index=11&type=chunk) - Year-to-date net cash flow from operating activities increased by **13,432.93%**, primarily due to increased sales and improved customer cash collections[12](index=12&type=chunk) - Total R&D investment increased by **111.35%** year-to-date and **131.77%** in the current period, mainly due to an increase in R&D personnel and their compensation, as well as increased amortization of development software and material expenditures for R&D projects[12](index=12&type=chunk) [Shareholder Information](index=6&type